Work

Carpal tunnel syndrome (CTS) and exposure to vibration, repetitive wrist movements, and heavy manual work: a case-referent study.

Year: 1989
Type: article
Abstract: 1732 Objectives Gastrin-releasing peptide receptor (GRPR) is an established target for imaging GRPR positive prostate and breast cancers. The aim of this work was to evaluate Al18F-NOTA labeled bombesin congener in vitro and in vivo and compare to previously synthesized 18F and 68Ga analogues. Methods 4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 was conjugated to NOTA chelating agent giving precursor 1. Radiolabeling was performed using Al18F method. The reagents were heated in ethanol/0.1 M sodium acetate buffer pH 4.1 (1:2) at 105°C for 10 min. Separation of unreacted 18F-fluoride and inorganic salts was achieved by solid phase extraction using HLB Plus cartridge. Specific activity was calculated based on the initial quantity of the precursor used for the radiolabeling. PET imaging of PC-3 tumor xenografted mice was performed using a GE eXplore Vista PET/CT. Blocking studies were conducted in the presence of 50 µg bombesin. Biodistribution was done at 135 min post-injection. Results The radiolabeling with Al18F was quick (under 30 min, including formulation) and robust, giving Al18F-1 (Ki = 0.68 ± 0.06 nM, logD7.4 = -3.3) in 34 ± 8 % radiochemical yield (d.c.) with specific activities 25-50 GBq/μmol (0.7-1.6 Ci/μmol) (EOS). Ethanol as co-solvent decreased radiolysis during synthesis. In vivo PET studies using Al18F-1 showed high accumulation in tumor with excellent contrast. The biodistribution results indicated high radioactivity in the pancreas (5-20 %ID/g). Intestine, gallbladder and kidneys accumulated below 2 %ID/g each. Tumor uptake was 4.5 ± 0.8 %ID/g. Tumor to blood and tumor to muscle ratios were 58 and 57, respectively. The binding decreased at blocking conditions to 1.6 ± 0.4 %ID/g, confirming specificity. Conclusions Al18F-1 is a promising tracer to image GRPR positive tumors. It was superior to the in-house clinical PoM bombesin analogue in delineating PC-3 tumor in mice
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2010784890
FWCI: 6.498
Cites: 27
Cited by: 230
Related to: 9